Introduction:Basic information about CAS 87-51-4|3-Indoleacetic acid, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 3-Indoleacetic acid |
|---|
| CAS Number | 87-51-4 | Molecular Weight | 175.184 |
|---|
| Density | 1.4±0.1 g/cm3 | Boiling Point | 415.0±20.0 °C at 760 mmHg |
|---|
| Molecular Formula | C10H9NO2 | Melting Point | 165-169 °C(lit.) |
|---|
| MSDS | ChineseUSA | Flash Point | 204.8±21.8 °C |
|---|
Names
| Name | indole-3-acetic acid |
|---|
| Synonym | More Synonyms |
|---|
3-Indoleacetic acid BiologicalActivity
| Description | Indole-3-acetic acid (3-Indoleacetic acid; IAA) is the most common natural plant growth hormone of the auxin class. It can be added to cell culture medium to induce plant cell elongation and division. |
|---|
| Related Catalog | Research Areas >>OthersBiochemical Assay ReagentsNatural Products >>Saccharides and Glycosides |
|---|
| Target | Human Endogenous Metabolite |
|---|
Chemical & Physical Properties
| Density | 1.4±0.1 g/cm3 |
|---|
| Boiling Point | 415.0±20.0 °C at 760 mmHg |
|---|
| Melting Point | 165-169 °C(lit.) |
|---|
| Molecular Formula | C10H9NO2 |
|---|
| Molecular Weight | 175.184 |
|---|
| Flash Point | 204.8±21.8 °C |
|---|
| Exact Mass | 175.063324 |
|---|
| PSA | 53.09000 |
|---|
| LogP | 1.43 |
|---|
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
|---|
| Index of Refraction | 1.694 |
|---|
| InChIKey | SEOVTRFCIGRIMH-UHFFFAOYSA-N |
|---|
| SMILES | O=C(O)Cc1c[nH]c2ccccc12 |
|---|
| Storage condition | −20°C |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- NL3150000
- CHEMICAL NAME :
- 1H-Indole-3-acetic acid
- CAS REGISTRY NUMBER :
- 87-51-4
- LAST UPDATED :
- 199710
- DATA ITEMS CITED :
- 16
- MOLECULAR FORMULA :
- C10-H9-N-O2
- MOLECULAR WEIGHT :
- 175.20
- WISWESSER LINE NOTATION :
- T56 BMJ D1VQ
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD - Lethal dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >500 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 150 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 2000 mg/kg/20W-I
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumor types after systemic administration not seen spontaneously
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 4500 mg/kg
- SEX/DURATION :
- female 7-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 450 mg/kg
- SEX/DURATION :
- female 7-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 4500 mg/kg
- SEX/DURATION :
- female 7-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - Central Nervous System
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 4500 mg/kg
- SEX/DURATION :
- female 7-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
MUTATION DATA - TYPE OF TEST :
- DNA damage
- TEST SYSTEM :
- Mammal - species unspecified Lymphocyte
- DOSE/DURATION :
- 250 umol/L
- REFERENCE :
- PYTCAS Phytochemistry. An International Journal of Plant Biochemistry. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1961- Volume(issue)/page/year: 11,3135,1972 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 83421 No. of Facilities: 5 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 27 (estimated)
|
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|
| Hazard Codes | Xi: Irritant; |
|---|
| Risk Phrases | R36/37/38 |
|---|
| Safety Phrases | S22-S24/25 |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| WGK Germany | 3 |
|---|
| RTECS | NL3150000 |
|---|
| Packaging Group | II |
|---|
| HS Code | 2933990090 |
|---|
Customs
| HS Code | 2933990090 |
|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Articles239
More Articles
| A new enabling proteomics methodology to investigate membrane associated proteins from parasitic nematodes: case study using ivermectin resistant and ivermectin susceptible isolates of Caenorhabditis elegans and Haemonchus contortus. Vet. Parasitol. 207(3-4) , 266-75, (2015) The mechanisms involved in anthelmintic resistance (AR) are complex but a greater understanding of AR management is essential for effective and sustainable control of parasitic helminth worms in lives... | |
| FCA mediates thermal adaptation of stem growth by attenuating auxin action in Arabidopsis. Nat. Commun. 5 , 5473, (2014) Global warming is predicted to profoundly affect plant distribution and crop yield in the near future. Higher ambient temperature can influence diverse aspects of plant growth and development. In Arab... | |
| Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis. Tumour Biol. 36(3) , 1711-20, (2015) The current methods available for screening and detecting cervical squamous cell carcinoma (CSCC) have insufficient sensitivity and specificity. As a result, many patients suffered from erroneous and ... | |
Synonyms
| 1H-Indol-3-ylacetic acid |
| INDOLYL 3-ACETIC ACID |
| 1H-Indole-3-acetic acid |
| b-Iaa |
| 3-(Carboxymethyl)Indole |
| 2-(1H-INDOL-3-YL)ACETIC ACID |
| 2-(3-Indolyl)acetic acid |
| INDOLE3ACETICACID |
| 3-Indolyl-acetic acid |
| 3-Indolylacetic Acid |
| a-Iaa |
| (1H-INDOL-3-YL)ACETIC ACID |
| β-indoleacetic acid |
| 1H-indol-3-acetic acid |
| Indole-3-aceticacid |
| EINECS 201-748-2 |
| MFCD00005636 |
| Heterauxin |
| (1H-indol-3-yl)-acetic acid |
| Noclosan |
| RHIZOPIN |
| INDOLE-3-BUTYRICACID |
| Indole-3-acetic acid |
| (INDOL-3-YL)ACETIC ACID |
| heteroauxin |
| 3-Indoleacetic Acid |
| IAA |
| INDOL-3-YLACETIC ACID |
| alpha-indol-3-yl-aceticacid |
| JAA |
| 3-INDOLEACETIC ACID,INDOLE-3-ACETIC ACID |
| 3-INDOLE ACETIC ACID |
| indole-3-acetate |
| 3-INDOLEACETICACID |
| 1-(4-FLUOROPHENYL)ETHAN-1-ONE |
| T56 BMJ D1VQ |
| α-Indol-3-yl-acetic acid |
| indoleacetic acid |
| alpha-Indol-3-yl-acetic acid |
| Acetic acid, indolyl- |
| Gap |
| [3H]-Indoleacetic acid |
| INDOLEI-3-ACETIC ACID |
| INDOLEACETIC ACID,OFF-WHITE SOLID |